Abstract
Purpose
Endometrial carcinoma is seen usually in the postmenopausal age. There are only case reports in the women aged 30 years or less. The aim was to evaluate endometrial carcinoma in women aged 30 years or younger and share our experience in the management of this malignancy in this young age.
Methods and Material
This was a retrospective study from January 2008 to January 2020. A total of 12 out of 562 patients of carcinoma endometrium were of age 30 years or younger. All patients underwent surgical staging. The required data were collected for the clinical and histopathological analysis. Institutional ethical committee approval was taken.
Results
The incidence of carcinoma endometrium in women up to 30 years of age was 2.1%. The patients were of the age of 26 to30 years. The common associations were obesity, nulliparity, infertility and polycystic ovarian pattern on imaging. Most of the cases had early stage disease with < 50% involvement of myometrium, but cases of advanced stage, moderate or high grade and > 50% involvement of myometrium were also seen.
Conclusions
Carcinoma endometrium in women aged 30 years or less is very rare. It is usually associated with endometrioid histology, early stage disease and very good outcome, but we can have adverse prognostic factors such as high grade disease and lymphovascular space invasion. Conservative management may be offered only in selective patients.
Similar content being viewed by others
References
American Cancer Society. Facts & figures 2019. Atlanta: American Cancer Society; 2019.
Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989;261:737–43.
Wingo PA, Cardinez CJ, Landis SH, et al. Long-term trends in cancer mortality in the United States, 1930–1998. Cancer. 2003;97:3133–275.
Yang DX, Soulos PR, et al. Impact of widespread cervical cancer screening: number of cancers prevented and changes in race-specific incidence. Am J Clin Oncol. 2018;41(3):289–94.
Gu M, Shi W, Barakat RR, Thaler HT, Saigo PE. Pap smears in women with endometrial carcinoma. Acta Cytol. 2001;45:555–60.
Siebers AG, Verbeck ALM, Massuger LF, et al. Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value of significant endometrial pathology. Int J Gynecol Cancer. 2006;16:1069–74.
Zucker PK, Kasdon EJ, Feldstein ML. The validity of pap smear parameters as predictors of endometrial pathology in menopausal women. Cancer. 1985;56:2256–63.
Langer RD, Pierce JJ, O’Hanlan KA, et al. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/progestin interventions trial. Engl J Med. 1997;337:1792–8.
Ng AB, Reagan JW, Hawliczek S, et al. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol. 1974;18:356–61.
Chiva L, Lapuente F, Gonzalez-Cortijo L. Sparing fertility in young patients with endometrial cancer. Gynecol Oncol. 2008;111:101–4.
Manfredi R, Mirk P, Maresca G, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology. 2004;231:372.
Simpson AN, Feigenberg T, Clarke BA, et al. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin. Gynecol Oncol. 2014;133:229.
Gitsch G, Hanzal E, Jensen D, et al. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol. 1995;85:504–8.
Walsh C, Holschneider C, Hoang Y, et al. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106:693–9.
Richter CE, Qian B, Martel M, et al. Ovarian preservation and staging in reproductive-age endometrial cancer patients. Gynecol Oncol. 2009;114:99–104.
Chapman JA, DiSaia PJ, Osann K, et al. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol. 1996;175:1195.
Suriano KA, McHale M, McLaren CE, et al. Estrogen replacement therapy in endometrial cancer patients: a matched control study. Obstet Gynecol. 2001;97:555.
Barakat RR, Bundy BN, Spirtos NM, et al. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a gynecologic oncology group study. J Clin Oncol. 2006;24:587.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical Approval
The study has been approved by the appropriate institutional research ethics committee and has been performed in accordance with the required ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dalal, V.K., Dave, P.S., Patel, B. et al. Carcinoma Endometrium in Women aged 30 Years and Younger: An Unusual Age of Presentation. Indian J Gynecol Oncolog 18, 57 (2020). https://doi.org/10.1007/s40944-020-00403-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40944-020-00403-w